Chylothorax

Revision as of 23:20, 26 February 2017 by Kxl328 (talk | contribs)

Background

Clinical Features

Differential Diagnosis

Acute dyspnea

Emergent

Non-Emergent

Evaluation

  • CXR
  • ECG
  • CBC, BMP
  • +/- BNP, D-dimer, Troponin to rule out other etiology
  • +/- Bedside lung ultrasound
  • Thoracentesis with classically white, odorless, milky fluid:
    • Differentiate from empyema and pseudochylothorax
      • Triglycerides
      • Cholesterol
      • LDH
      • Protein
      • Culture and gram stain
      • Cell differential and count
  • Serum LDH and total protein comparison

Management

  • Thoracic duct leaks close spontaneously in ~50% of patients[1]
  • Treat underlying cause (e.g. chemoradiation for malignancy)
  • Refractory: pleurodesis, thoracic duct ligation, pleuroperitoneal shunt, pleurectomy

Disposition

See Also

External Links

References

  1. Bender B, Murthy V, Chamberlain RS. The changing management of chylothorax in the modern era. Eur J Cardiothorac Surg. 2016 Jan. 49 (1):18-24. [Medline]